Vanguard Group’s Elicio Therapeutics ELTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Buy |
454,619
+132,925
| +41% | +$1.03M | ﹤0.01% | 3324 |
|
|
2025
Q1 | $1.98M | Buy |
321,694
+75,871
| +31% | +$467K | ﹤0.01% | 3493 |
|
|
2024
Q4 | $1.2M | Buy |
245,823
+561
| +0.2% | +$2.75K | ﹤0.01% | 3703 |
|
|
2024
Q3 | $1.23M | Buy |
245,262
+18,965
| +8% | +$95.4K | ﹤0.01% | 3709 |
|
|
2024
Q2 | $930K | Buy |
226,297
+10,611
| +5% | +$43.6K | ﹤0.01% | 3809 |
|
|
2024
Q1 | $1.64M | Buy |
215,686
+40,792
| +23% | +$310K | ﹤0.01% | 3656 |
|
|
2023
Q4 | $1.46M | Buy |
174,894
+34,367
| +24% | +$287K | ﹤0.01% | 3712 |
|
|
2023
Q3 | $1.19M | Buy |
140,527
+69,777
| +99% | +$590K | ﹤0.01% | 3768 |
|
|
2023
Q2 | $672K | Sell |
70,750
-573,285
| -89% | -$5.45M | ﹤0.01% | 4029 |
|
|
2023
Q1 | $374K | Hold |
644,035
| – | – | ﹤0.01% | 4200 |
|
|
2022
Q4 | $523K | Buy |
644,035
+675
| +0.1% | +$548 | ﹤0.01% | 4085 |
|
|
2022
Q3 | $592K | Sell |
643,360
-127,334
| -17% | -$117K | ﹤0.01% | 4167 |
|
|
2022
Q2 | $878K | Buy |
770,694
+135,851
| +21% | +$155K | ﹤0.01% | 4129 |
|
|
2022
Q1 | $1.35M | Sell |
634,843
-268,290
| -30% | -$569K | ﹤0.01% | 4119 |
|
|
2021
Q4 | $2.62M | Buy |
903,133
+2,088
| +0.2% | +$6.05K | ﹤0.01% | 3941 |
|
|
2021
Q3 | $8.8M | Buy |
901,045
+648,753
| +257% | +$6.34M | ﹤0.01% | 3318 |
|
|
2021
Q2 | $3.29M | Sell |
252,292
-519,643
| -67% | -$6.77M | ﹤0.01% | 3802 |
|
|
2021
Q1 | $14M | Buy |
+771,935
| New | +$14M | ﹤0.01% | 2973 |
|